Global Liposome Drug Delivery Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch's in-depth investigation and research, the global Liposome Drug Delivery market size will reach 5,732.36 Million USD in 2025 and is projected to reach 12,075 Million USD by 2032, with a CAGR of 11.23% (2025-2032). Notably, the China Liposome Drug Delivery market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Liposome drug delivery is a method of delivering drugs to targeted cells or tissues using liposomes - small, spherical, biocompatible and biodegradable vesicles composed of phospholipids. Liposomes can be loaded with drugs and designed to release the drug in a specific target-controlled manner. The liposomes act as carriers that have the ability to increase the bioavailability of the drug and improve the efficacy of treatment while reducing the toxicity of the drug. Liposome drug delivery is commonly used in the treatment of cancer, infectious diseases, and inflammation. The technology is also useful in enhancing the delivery of large therapeutic molecules, such as peptides, proteins, or nucleic acids, that would otherwise not be adequately absorbed.
The major global suppliers of Liposome Drug Delivery include Gilead Sciences, Pacira, Sun Pharmaceutical, Johnson & Johnson, Luye Pharma, Sigma-Tau, Ipsen (Onivyde), CSPC, Teva Pharmaceutical, Novartis, Fudan-Zhangjiang, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Liposome Drug Delivery. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Liposome Drug Delivery market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Liposome Drug Delivery market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Liposome Drug Delivery industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Liposome Drug Delivery Include:
Gilead Sciences
Pacira
Sun Pharmaceutical
Johnson & Johnson
Luye Pharma
Sigma-Tau
Ipsen (Onivyde)
CSPC
Teva Pharmaceutical
Novartis
Fudan-Zhangjiang
Liposome Drug Delivery Product Segment Include:
Liposomal Doxorubicin
Liposomal Amphoteracin B
Liposomal Paclitaxel
Others
Liposome Drug Delivery Product Application Include:
Fungal Infection Therapy
Cancer & Tumor Therapy
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Liposome Drug Delivery Industry PESTEL Analysis
Chapter 3: Global Liposome Drug Delivery Industry Porter's Five Forces Analysis
Chapter 4: Global Liposome Drug Delivery Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Liposome Drug Delivery Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Liposome Drug Delivery Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Liposome Drug Delivery Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
According to DIResearch's in-depth investigation and research, the global Liposome Drug Delivery market size will reach 5,732.36 Million USD in 2025 and is projected to reach 12,075 Million USD by 2032, with a CAGR of 11.23% (2025-2032). Notably, the China Liposome Drug Delivery market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Liposome drug delivery is a method of delivering drugs to targeted cells or tissues using liposomes - small, spherical, biocompatible and biodegradable vesicles composed of phospholipids. Liposomes can be loaded with drugs and designed to release the drug in a specific target-controlled manner. The liposomes act as carriers that have the ability to increase the bioavailability of the drug and improve the efficacy of treatment while reducing the toxicity of the drug. Liposome drug delivery is commonly used in the treatment of cancer, infectious diseases, and inflammation. The technology is also useful in enhancing the delivery of large therapeutic molecules, such as peptides, proteins, or nucleic acids, that would otherwise not be adequately absorbed.
The major global suppliers of Liposome Drug Delivery include Gilead Sciences, Pacira, Sun Pharmaceutical, Johnson & Johnson, Luye Pharma, Sigma-Tau, Ipsen (Onivyde), CSPC, Teva Pharmaceutical, Novartis, Fudan-Zhangjiang, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Liposome Drug Delivery. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Liposome Drug Delivery market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Liposome Drug Delivery market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Liposome Drug Delivery industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Liposome Drug Delivery Include:
Gilead Sciences
Pacira
Sun Pharmaceutical
Johnson & Johnson
Luye Pharma
Sigma-Tau
Ipsen (Onivyde)
CSPC
Teva Pharmaceutical
Novartis
Fudan-Zhangjiang
Liposome Drug Delivery Product Segment Include:
Liposomal Doxorubicin
Liposomal Amphoteracin B
Liposomal Paclitaxel
Others
Liposome Drug Delivery Product Application Include:
Fungal Infection Therapy
Cancer & Tumor Therapy
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Liposome Drug Delivery Industry PESTEL Analysis
Chapter 3: Global Liposome Drug Delivery Industry Porter's Five Forces Analysis
Chapter 4: Global Liposome Drug Delivery Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Liposome Drug Delivery Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Liposome Drug Delivery Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Liposome Drug Delivery Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Table of Contents
165 Pages
- 1 Liposome Drug Delivery Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Liposome Drug Delivery Product by Type
- 1.2.1 Liposomal Doxorubicin
- 1.2.2 Liposomal Amphoteracin B
- 1.2.3 Liposomal Paclitaxel
- 1.2.4 Others
- 1.3 Liposome Drug Delivery Product by Application
- 1.3.1 Fungal Infection Therapy
- 1.3.2 Cancer & Tumor Therapy
- 1.3.3 Others
- 1.4 Global Liposome Drug Delivery Market Size Analysis (2020-2032)
- 1.5 Liposome Drug Delivery Market Development Status and Trends
- 1.5.1 Liposome Drug Delivery Industry Development Status Analysis
- 1.5.2 Liposome Drug Delivery Industry Development Trends Analysis
- 2 Liposome Drug Delivery Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Liposome Drug Delivery Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Liposome Drug Delivery Market Analysis by Country
- 4.1 Global Liposome Drug Delivery Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global Liposome Drug Delivery Revenue Analysis by Country (2020-2025)
- 4.1.2 Global Liposome Drug Delivery Revenue Forecast Analysis by Country (2026-2032)
- 4.2 United States Liposome Drug Delivery Market Revenue and Growth Rate (2020-2032)
- 4.3 Germany Liposome Drug Delivery Market Revenue and Growth Rate (2020-2032)
- 4.4 Japan Liposome Drug Delivery Market Revenue and Growth Rate (2020-2032)
- 4.5 China Liposome Drug Delivery Market Revenue and Growth Rate (2020-2032)
- 4.6 France Liposome Drug Delivery Market Revenue and Growth Rate (2020-2032)
- 4.7 U.K. Liposome Drug Delivery Market Revenue and Growth Rate (2020-2032)
- 4.8 South Korea Liposome Drug Delivery Market Revenue and Growth Rate (2020-2032)
- 4.9 Canada Liposome Drug Delivery Market Revenue and Growth Rate (2020-2032)
- 4.10 Italy Liposome Drug Delivery Market Revenue and Growth Rate (2020-2032)
- 4.11 Russia Liposome Drug Delivery Market Revenue and Growth Rate (2020-2032)
- 4.12 Mexico Liposome Drug Delivery Market Revenue and Growth Rate (2020-2032)
- 4.13 Brazil Liposome Drug Delivery Market Revenue and Growth Rate (2020-2032)
- 4.14 India Liposome Drug Delivery Market Revenue and Growth Rate (2020-2032)
- 4.15 Vietnam Liposome Drug Delivery Market Revenue and Growth Rate (2020-2032)
- 4.16 Thailand Liposome Drug Delivery Market Revenue and Growth Rate (2020-2032)
- 4.17 South Africa Liposome Drug Delivery Market Revenue and Growth Rate (2020-2032)
- 5 Competition by Suppliers
- 5.1 Global Liposome Drug Delivery Market Revenue by Key Suppliers (2021-2025)
- 5.2 Liposome Drug Delivery Competitive Landscape Analysis and Market Dynamic
- 5.2.1 Liposome Drug Delivery Competitive Landscape Analysis
- 5.2.2 Global Key Suppliers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 Liposome Drug Delivery Market Analysis by Type
- 6.1 Global Liposome Drug Delivery Market Size Analysis by Type: 2024 VS 2025 VS 2032
- 6.2 Global Liposome Drug Delivery Revenue and Forecast Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 Gilead Sciences
- 7.1.1 Gilead Sciences Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 Gilead Sciences Liposome Drug Delivery Product Portfolio
- 7.1.3 Gilead Sciences Liposome Drug Delivery Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.2 Pacira
- 7.2.1 Pacira Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 Pacira Liposome Drug Delivery Product Portfolio
- 7.2.3 Pacira Liposome Drug Delivery Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.3 Sun Pharmaceutical
- 7.3.1 Sun Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 Sun Pharmaceutical Liposome Drug Delivery Product Portfolio
- 7.3.3 Sun Pharmaceutical Liposome Drug Delivery Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.4 Johnson & Johnson
- 7.4.1 Johnson & Johnson Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 Johnson & Johnson Liposome Drug Delivery Product Portfolio
- 7.4.3 Johnson & Johnson Liposome Drug Delivery Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.5 Luye Pharma
- 7.5.1 Luye Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.5.2 Luye Pharma Liposome Drug Delivery Product Portfolio
- 7.5.3 Luye Pharma Liposome Drug Delivery Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.6 Sigma-Tau
- 7.6.1 Sigma-Tau Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.6.2 Sigma-Tau Liposome Drug Delivery Product Portfolio
- 7.6.3 Sigma-Tau Liposome Drug Delivery Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.7 Ipsen (Onivyde)
- 7.7.1 Ipsen (Onivyde) Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.7.2 Ipsen (Onivyde) Liposome Drug Delivery Product Portfolio
- 7.7.3 Ipsen (Onivyde) Liposome Drug Delivery Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.8 CSPC
- 7.8.1 CSPC Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.8.2 CSPC Liposome Drug Delivery Product Portfolio
- 7.8.3 CSPC Liposome Drug Delivery Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.9 Teva Pharmaceutical
- 7.9.1 Teva Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.9.2 Teva Pharmaceutical Liposome Drug Delivery Product Portfolio
- 7.9.3 Teva Pharmaceutical Liposome Drug Delivery Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.10 Novartis
- 7.10.1 Novartis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.10.2 Novartis Liposome Drug Delivery Product Portfolio
- 7.10.3 Novartis Liposome Drug Delivery Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.11 Fudan-Zhangjiang
- 7.11.1 Fudan-Zhangjiang Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.11.2 Fudan-Zhangjiang Liposome Drug Delivery Product Portfolio
- 7.11.3 Fudan-Zhangjiang Liposome Drug Delivery Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 8 Industry Chain Analysis
- 8.1 Liposome Drug Delivery Industry Chain Analysis
- 8.2 Liposome Drug Delivery Product Downstream Application Analysis
- 8.2.1 Global Liposome Drug Delivery Market Size and Growth Rate (CAGR) by Application: 2024 VS 2025 VS 2032
- 8.2.2 Global Liposome Drug Delivery Revenue and Forecast by Application (2020-2032)
- 8.3 Liposome Drug Delivery Typical Downstream Customers
- 8.4 Liposome Drug Delivery Sales Channel Analysis
- 9 Research Findings and Conclusion
- 10 Methodology and Data Source
- 10.1 Methodology/Research Approach
- 10.2 Research Scope
- 10.3 Benchmarks and Assumptions
- 10.4 Date Source
- 10.4.1 Primary Sources
- 10.4.2 Secondary Sources
- 10.5 Data Cross Validation
- 10.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
